Analysis | Metabolite Name | Measured Value | Units | Construct |
---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+CL)- | 1560 | Peak area | Control lentivirus |
Reversed phase NEGATIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+CL)- | 20191 | Peak area | Noxa knockdown |
Reversed phase NEGATIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+CL)- | 1448538 | Peak area | Control lentivirus |
Reversed phase NEGATIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+CL)- | Peak area | Control lentivirus | |
Reversed phase NEGATIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+CL)- | Peak area | Noxa knockdown | |
Reversed phase NEGATIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+HCOO)- | 1339 | Peak area | Noxa knockdown |
Reversed phase NEGATIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+HCOO)- | 1646 | Peak area | Control lentivirus |
Reversed phase NEGATIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+HCOO)- | 20134 | Peak area | Noxa knockdown |
Reversed phase NEGATIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+HCOO)- | 1099613 | Peak area | Control lentivirus |
Reversed phase NEGATIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+HCOO)- | Peak area | Control lentivirus | |
Reversed phase NEGATIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+HCOO)- | Peak area | Noxa knockdown | |
Reversed phase POSITIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+H)+ | 125537 | Peak area | Control lentivirus |
Reversed phase POSITIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+H)+ | Peak area | Control lentivirus | |
Reversed phase POSITIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+H)+ | Peak area | Noxa knockdown | |
Reversed phase POSITIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+NA)+ | 25917 | Peak area | Noxa knockdown |
Reversed phase POSITIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+NA)+ | 1332489 | Peak area | Control lentivirus |
Reversed phase POSITIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+NA)+ | Peak area | Control lentivirus | |
Reversed phase POSITIVE ION MODE | CORTISONE (CAS# 53-06-5); (M+NA)+ | Peak area | Noxa knockdown |